2026-09-14

#reports #JAKK

[JAKKS Pacific](https://eninvs.com/all.php?name=JAKK) (Leisure) reported for 2026 q2
(2026-04-30, After Market Close):

- Revenue +16.8% YoY (vs -5.3% in previous quarter and historical rate -4.0%)
- EV/EBITDA multiple is 33.7x compared to historical level (75th percentile) of 14.4x
- EV/Sales multiple is 1.2x

------------------------------------------------

2026-09-14

#reports #JACK

[Jack in the Box](https://eninvs.com/all.php?name=JACK) (Restaurant chain) reported for 2026 q2
(2026-05-13, After Market Close):

- Revenue -83.6% YoY (vs -31.2% in previous quarter and historical rate +4.8%)
- EBITDA -54.3% YoY (vs +4500.0% in previous quarter and historical rate +2.1%)
- EBITDA margin 24.4% increased compared to 8.8% same period last year
- EV/EBITDA multiple is 1.4x compared to historical level (75th percentile) of 12.7x
- EV/Sales multiple is 0.3x

------------------------------------------------

2026-09-14

#reports #ITW

[Illinois Tool Works](https://eninvs.com/all.php?name=ITW) (Fasteners manufacturer) reported for 2026 q2
(2026-04-30, Before Market Open):

- Revenue +6.1% YoY (vs +4.6% in previous quarter and historical rate +0.8%)
- EBITDA +2.8% YoY (vs +2.8% in previous quarter and historical rate +2.4%)
- EBITDA margin 28.6% decreased compared to 29.5% same period last year
- Net Debt increased by $534 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$2 bln (positive), 2.4% of market cap
- EV/EBITDA multiple is 19.6x compared to historical level (75th percentile) of 19.5x
- EV/Sales multiple is 5.6x

------------------------------------------------

2026-09-14

#reports #ITT

[ITT](https://eninvs.com/all.php?name=ITT) (Engineering component manufacturer) reported for 2026 q2
(2026-05-06, Before Market Open):

- Revenue +51.5% YoY (vs +32.7% in previous quarter and historical rate +23.3%)
- EBITDA +30.8% YoY (vs +3.7% in previous quarter and historical rate +29.2%)
- EBITDA margin 18.7% decreased compared to 21.7% same period last year
- EV/EBITDA multiple is 10.5x compared to historical level (75th percentile) of 16.8x
- EV/Sales multiple is 3.4x

------------------------------------------------

2026-09-14

#reports #ITGR

[Integer Corporation](https://eninvs.com/all.php?name=ITGR) (Medical device manufacturer) reported for 2026 q2
(2026-04-30, Before Market Open):

- Revenue -2.5% YoY (vs +0.7% in previous quarter and historical rate +7.4%)
- EBITDA -25% YoY (vs -15.2% in previous quarter and historical rate +9.0%)
- EBITDA margin 14.9% decreased compared to 19.3% same period last year
- Net Debt decreased by $30 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 18.2x compared to historical level (75th percentile) of 18.3x
- EV/Sales multiple is 3.1x

------------------------------------------------

2026-09-14

#reports #IT

[Gartner](https://eninvs.com/all.php?name=IT) (Research and consulting service provider) reported for 2026 q2
(2026-05-05, Before Market Open):

- Revenue -0.6% YoY (vs -1.5% in previous quarter and historical rate +4.0%)
- EBITDA +12.8% YoY (vs +11.1% in previous quarter and historical rate -4.4%)
- EBITDA margin 24.1% increased compared to 21.2% same period last year
- Net Debt increased by $153 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$1.1 bln (positive), 8.0% of market cap
- EV/EBITDA multiple is 12.7x compared to historical level (75th percentile) of 30x
- EV/Sales multiple is 2.4x

------------------------------------------------

2026-09-14

#reports #IRWD

[Ironwood Pharmaceuticals](https://eninvs.com/all.php?name=IRWD) (Drug Manufacturers — Specialty and Generic) reported for 2026 q2
(2026-05-07, Before Market Open):

- Revenue +32.9% YoY (vs +161.0% in previous quarter and historical rate +4.8%)
- EBITDA +77.8% YoY (vs +7200.0% in previous quarter and historical rate +31.3%)
- EBITDA margin 70.8% increased compared to 52.9% same period last year
- EV/EBITDA multiple is 5.1x compared to historical level (75th percentile) of 7.7x
- EV/Sales multiple is 3.1x

------------------------------------------------

2026-09-14

#reports #IRTC

[iRhythm Technologies](https://eninvs.com/all.php?name=IRTC) (Medical device manufacturer) reported for 2026 q2
(2026-04-30, After Market Close):

- Revenue +19.8% YoY (vs +25.2% in previous quarter and historical rate +22.3%)
- EBITDA margin 1.3% increased compared to -7.5% same period last year
- EV/Sales multiple is 4.5x

------------------------------------------------

2026-09-14

#reports #IRMD

[IRadimed Corporation](https://eninvs.com/all.php?name=IRMD) (Medical Devices) reported for 2026 q2
(2026-05-01, Before Market Open):

- Revenue 0% YoY (vs +10.0% in previous quarter and historical rate +13.7%)
- EBITDA 0% YoY (vs +33.3% in previous quarter and historical rate +20.3%)
- EBITDA margin 35.0% has not changed compared to 35.0% same period last year
- EV/EBITDA multiple is 34.3x compared to historical level (75th percentile) of 40.8x
- EV/Sales multiple is 11.6x

------------------------------------------------

2026-09-14

#reports #IRDM

[Iridium Communications](https://eninvs.com/all.php?name=IRDM) (Mobile satellite provider) reported for 2026 q2
(2026-04-23, Before Market Open):

- Revenue +3.7% YoY (vs +1.9% in previous quarter and historical rate +4.5%)
- EBITDA -14.6% YoY (vs -7.1% in previous quarter and historical rate +3.9%)
- EBITDA margin 39.1% decreased compared to 47.5% same period last year
- EV/EBITDA multiple is 13.9x compared to historical level (75th percentile) of 10.9x
- EV/Sales multiple is 6.7x

------------------------------------------------

2026-09-14

#reports #IQV

[IQVIA](https://eninvs.com/all.php?name=IQV) (Analytical company) reported for 2026 q2
(2026-05-05, Before Market Open):

- Revenue +8.7% YoY (vs +8.4% in previous quarter and historical rate +5.0%)
- EBITDA +2% YoY (vs +5.4% in previous quarter and historical rate +6.8%)
- EBITDA margin 18.3% decreased compared to 19.5% same period last year
- Net Debt increased by $204 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$1 bln (positive), 2.1% of market cap
- EV/EBITDA multiple is 17.1x compared to historical level (75th percentile) of 17.4x
- EV/Sales multiple is 3.7x

------------------------------------------------

2026-09-14

#reports #IPGP

[IPG Photonics](https://eninvs.com/all.php?name=IPGP) (Fiber laser manufacturer) reported for 2026 q2
(2026-05-05, Before Market Open):

- Revenue +11.2% YoY (vs +16.2% in previous quarter and historical rate -6.7%)
- EBITDA +25% YoY (vs -52.9% in previous quarter and historical rate -2.1%)
- EBITDA margin 7.2% increased compared to 6.4% same period last year
- EV/EBITDA multiple is 22.4x compared to historical level (75th percentile) of 22.6x
- EV/Sales multiple is 2.4x

------------------------------------------------

2026-09-14

#reports #IPAR

[Inter Parfums](https://eninvs.com/all.php?name=IPAR) (Perfume manufacturer) reported for 2026 q2
(2026-05-05, After Market Close):

- Revenue +2.1% YoY (vs +1.8% in previous quarter and historical rate +10.0%)
- EBITDA -16.7% YoY (vs -1.2% in previous quarter and historical rate +15.0%)
- EBITDA margin 16.1% decreased compared to 19.8% same period last year
- EV/EBITDA multiple is 13.5x compared to historical level (75th percentile) of 15.9x
- EV/Sales multiple is 2.5x

------------------------------------------------

2026-09-14

#reports #IOVA

[Iovance Biotherapeutics](https://eninvs.com/all.php?name=IOVA) (Anti-cancer immunotherapies manufacturer) reported for 2026 q2
(2026-05-07, Before Market Open):

- Revenue +102% YoY (vs +20.3% in previous quarter and historical rate +76.9%)
- EBITDA margin -42.4% increased compared to -242.9% same period last year
- EV/Sales multiple is 4.6x

------------------------------------------------

2026-09-14

#reports #IOT

[Samsara Inc.](https://eninvs.com/all.php?name=IOT) (Software — Infrastructure) reported for 2026 q2
(2026-06-04, After Market Close):

- Revenue +29.9% YoY (vs +30.5% in previous quarter and historical rate +37.4%)
- EBITDA margin 2.6% increased compared to -5.4% same period last year
- EV/Sales multiple is 10.2x

------------------------------------------------

2026-09-14

#reports #IOSP

[Innospec](https://eninvs.com/all.php?name=IOSP) (Specialty chemicals manufacturer ) reported for 2026 q2
(2026-05-07, After Market Close):

- Revenue +11.6% YoY (vs +2.7% in previous quarter and historical rate -2.5%)
- EBITDA +11.1% YoY (vs -13.2% in previous quarter and historical rate -5.0%)
- EBITDA margin 10.2% has not changed compared to 10.2% same period last year
- EV/EBITDA multiple is 12.1x compared to historical level (75th percentile) of 12.2x
- EV/Sales multiple is 1.1x

------------------------------------------------

2026-09-14

#reports #IONS

[Ionis Pharmaceuticals](https://eninvs.com/all.php?name=IONS) (Drug Developer) reported for 2026 q2
(2026-02-25, Before Market Open):

- Revenue -40.7% YoY (vs +86.4% in previous quarter and historical rate +28.3%)
- EBITDA -167.6% YoY (vs -11400.0% in previous quarter and historical rate +2.7%)
- EBITDA margin -36.6% decreased compared to 32.1% same period last year
- EV/Sales multiple is 8.8x

------------------------------------------------

2026-09-14

#reports #INVE

[Identiv](https://eninvs.com/all.php?name=INVE) (Computer Hardware) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=199418)
(2026-05-13, After Market Close):

- Revenue +40% YoY (vs -14.3% in previous quarter and historical rate -28.7%)
- EBITDA margin -57.1% increased compared to -60.0% same period last year
- Net Debt increased by $4 mln over the past reporting period (6.6% of market cap)
- FCF (LTM) -$0 bln (negative), 16.6% of market cap
- EV/EBITDA multiple is 3.4x compared to historical level (75th percentile) of 2.8x
- EV/Sales multiple is -2.8x

------------------------------------------------

2026-09-14

#reports #INVA

[Innoviva](https://eninvs.com/all.php?name=INVA) (Biotechnology) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=198555)
(2026-05-06, After Market Close):

- Revenue +10.1% YoY (vs +25.0% in previous quarter and historical rate +11.8%)
- EBITDA -6.7% YoY (vs +44.8% in previous quarter and historical rate +31.8%)
- EBITDA margin 42.9% decreased compared to 50.6% same period last year
- Net Debt decreased by $53 mln over the past reporting period (3.5% of market cap)
- FCF (LTM) +$0.5 bln (positive), 32.4% of market cap
- EV/EBITDA multiple is 7x compared to historical level (75th percentile) of 8x
- EV/Sales multiple is 2.8x

------------------------------------------------

2026-09-14

#reports #INTZ

[Intrusion](https://eninvs.com/all.php?name=INTZ) (Software — Infrastructure) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=199416)
(2026-03-24, After Market Close):

- Revenue -50% YoY (vs -50.0% in previous quarter and historical rate +16.7%)
- EBITDA margin -300.0% decreased compared to -100.0% same period last year
- Net Debt decreased by $2 mln over the past reporting period (151.6% of market cap)
- FCF (LTM) -$0 bln (negative), 303.2% of market cap
- EV/Sales multiple is 0.6x

------------------------------------------------

2026-09-14

#reports #INTU

[Intuit](https://eninvs.com/all.php?name=INTU) (Software developer) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=197304)
(2026-05-20, After Market Close):

- Revenue +10.4% YoY (vs +17.4% in previous quarter and historical rate +14.7%)
- EBITDA +10.4% YoY (vs +48.5% in previous quarter and historical rate +24.4%)
- EBITDA margin 48.5% has not changed compared to 48.5% same period last year
- Net Debt decreased by $3.7 bln since the start of the year (4.1% of market cap)
- FCF (LTM) +$6.3 bln (positive), 6.9% of market cap
- EV/EBITDA multiple is 15.4x compared to historical level (75th percentile) of 46.8x
- EV/Sales multiple is 4.3x

------------------------------------------------

2026-09-14

#reports #INSP

[Inspire Medical Systems](https://eninvs.com/all.php?name=INSP) (Medical device developer) reported for 2026 q2
(2026-05-04, After Market Close):

- Revenue -7.4% YoY (vs +2.0% in previous quarter and historical rate +20.5%)
- EBITDA margin -0.5% increased compared to -1.4% same period last year
- EV/EBITDA multiple is 30.9x compared to historical level (75th percentile) of 111.4x
- EV/Sales multiple is 2.3x

------------------------------------------------

2026-09-14

#reports #INSM

[Insmed](https://eninvs.com/all.php?name=INSM) (Biotechnology) reported for 2026 q2
(2026-05-07, Before Market Open):

- Revenue +297.2% YoY (vs +229.0% in previous quarter and historical rate +65.1%)
- EBITDA margin 0.5% increased compared to -290.7% same period last year
- Net Debt increased by $63 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0.8 bln (negative), 3.1% of market cap
- EV/Sales multiple is 22.1x

------------------------------------------------

2026-09-14

#reports #INSG

[Inseego](https://eninvs.com/all.php?name=INSG) (Communication equipment developer) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=198056)
(2026-02-19, After Market Close):

- Revenue +6.3% YoY (vs +45.5% in previous quarter and historical rate -8.4%)
- EBITDA -250% YoY (vs 0.0% in previous quarter)
- EBITDA margin -8.8% decreased compared to 6.3% same period last year
- Net Debt increased by $14 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) -$0 bln (negative), 1.1% of market cap
- EV/EBITDA multiple is 67.4x compared to historical level (75th percentile) of 170.9x
- EV/Sales multiple is 3.3x

------------------------------------------------

2026-09-14

#reports #INN

[Summit Hotel Properties](https://eninvs.com/all.php?name=INN) (REIT — Hotel and Motel) reported for 2026 q2
(2026-04-30, After Market Close):

- Revenue +8.2% YoY (vs +4.5% in previous quarter and historical rate +4.2%)
- EBITDA +14% YoY (vs -1.9% in previous quarter and historical rate +8.2%)
- EBITDA margin 32.7% increased compared to 31.0% same period last year
- Net Debt decreased by $17 mln over the past reporting period (2.9% of market cap)
- FCF (LTM) +$0.2 bln (positive), 30.2% of market cap
- EV/EBITDA multiple is 8.7x compared to historical level (75th percentile) of 9.5x
- EV/Sales multiple is 2.6x

------------------------------------------------

2026-09-14

#reports #INGR

[Ingredion](https://eninvs.com/all.php?name=INGR) (Starch manufacturer) reported for 2026 q2
(2026-05-05, Before Market Open):

- Revenue +0.9% YoY (vs -1.2% in previous quarter and historical rate -4.2%)
- EBITDA -25% YoY (vs -22.1% in previous quarter and historical rate +1.7%)
- EBITDA margin 13.1% decreased compared to 17.7% same period last year
- Net Debt decreased by $76 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0.4 bln (positive), 5.3% of market cap
- EV/EBITDA multiple is 7x compared to historical level (75th percentile) of 8.7x
- EV/Sales multiple is 1x

------------------------------------------------

2026-09-14

#reports #INCY

[Incyte](https://eninvs.com/all.php?name=INCY) (Small molecule drugs developer) reported for 2026 q2
(2026-04-28, Before Market Open):

- Revenue +37.7% YoY (vs +20.9% in previous quarter and historical rate +18.5%)
- EBITDA +32.1% YoY (vs +42.5% in previous quarter and historical rate +50.2%)
- EBITDA margin 43.2% decreased compared to 45.1% same period last year
- EV/EBITDA multiple is 11.1x compared to historical level (75th percentile) of 54.1x
- EV/Sales multiple is 3.5x

------------------------------------------------

2026-09-14

#reports #IMMR

[Immersion Corporation](https://eninvs.com/all.php?name=IMMR) (Software — Application) reported for 2026 q1
(2026-07-01, After Market Close):

- Revenue -5.3% YoY (vs +9.1% in previous quarter and historical rate +86.0%)
- EBITDA +100% YoY (vs -64.4% in previous quarter and historical rate +39.2%)
- EBITDA margin 6.7% increased compared to 3.2% same period last year
- Net Debt decreased by $557 mln over the past reporting period (228.5% of market cap)
- FCF (LTM) +$0 bln (positive), 17.6% of market cap
- EV/EBITDA multiple is 2x compared to historical level (75th percentile) of 8.1x
- EV/Sales multiple is 0.1x

------------------------------------------------

2026-09-14

#reports #IMKTA

[Ingles Markets](https://eninvs.com/all.php?name=IMKTA) (Grocery Stores) reported for 2026 q2
(2026-05-11, Before Market Open):

- Revenue +2.8% YoY (vs +1.6% in previous quarter and historical rate +9.4%)
- EBITDA +25% YoY (vs +18.2% in previous quarter and historical rate -3.4%)
- EBITDA margin 4.8% increased compared to 3.9% same period last year
- Net Debt decreased by $41 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) +$0.2 bln (positive), 10.0% of market cap
- EV/EBITDA multiple is 6.1x compared to historical level (75th percentile) of 3.5x
- EV/Sales multiple is 0.3x

------------------------------------------------

2026-09-14

#reports #IIIN

[Insteel Industries](https://eninvs.com/all.php?name=IIIN) (Metal Fabrication) reported for 2026 q2
(2026-07-16, Before Market Open):

- Revenue +23% YoY (vs +33.1% in previous quarter and historical rate +0.6%)
- EBITDA -11.1% YoY (vs +83.3% in previous quarter and historical rate +3.7%)
- EBITDA margin 8.1% decreased compared to 11.2% same period last year
- EV/EBITDA multiple is 9.2x compared to historical level (75th percentile) of 13.3x
- EV/Sales multiple is 0.8x

------------------------------------------------

2026-09-14

#reports #III

[Information Services Group](https://eninvs.com/all.php?name=III) (Information Technology Services) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=199413)
(2026-04-16, Before Market Open):

- Revenue +1.7% YoY (vs +5.2% in previous quarter and historical rate -5.1%)
- EBITDA +50% YoY (vs +500.0% in previous quarter)
- EBITDA margin 9.8% increased compared to 6.7% same period last year
- Net Debt increased by $5 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) -$0 bln (negative), 1.2% of market cap
- EV/EBITDA multiple is 12.7x compared to historical level (75th percentile) of 19.4x
- EV/Sales multiple is 1.2x

------------------------------------------------

2026-09-14

#reports #IHRT

[iHeartMedia](https://eninvs.com/all.php?name=IHRT) (Broadcasting) reported for 2026 q2
(2026-05-11, After Market Close):

- Revenue +4.6% YoY (vs +9.5% in previous quarter and historical rate +1.6%)
- EBITDA -9.5% YoY (vs +25.8% in previous quarter and historical rate -4.4%)
- EBITDA margin 11.7% decreased compared to 13.5% same period last year
- Net Debt decreased by $41 mln over the past reporting period (9.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 24.2% of market cap
- EV/EBITDA multiple is 17.3x compared to historical level (75th percentile) of 1536x
- EV/Sales multiple is 1.5x

------------------------------------------------

2026-09-14

#reports #IFF

[International Flavors & Fragrances](https://eninvs.com/all.php?name=IFF) (Flavor manufacturer) reported for 2026 q2
(2026-05-05, After Market Close):

- Revenue +1.8% YoY (vs -3.6% in previous quarter and historical rate -5.2%)
- EBITDA -2.1% YoY (vs +51800.0% in previous quarter and historical rate +16.8%)
- EBITDA margin 19.2% decreased compared to 20.0% same period last year
- Net Debt decreased by $125 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.4 bln (positive), 1.9% of market cap
- EV/EBITDA multiple is 15.6x compared to historical level (75th percentile) of 16.1x
- EV/Sales multiple is 2.6x

------------------------------------------------

2026-09-14

#reports #IEX

[IDEX](https://eninvs.com/all.php?name=IEX) (Pump equipment manufacturer) reported for 2026 q2
(2026-02-04, Before Market Open):

- Revenue +6.5% YoY (vs +9.0% in previous quarter and historical rate +2.7%)
- EBITDA +6.3% YoY (vs +20.0% in previous quarter and historical rate -0.6%)
- EBITDA margin 23.9% has not changed compared to 23.9% same period last year
- Net Debt decreased by $48 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.5 bln (positive), 2.7% of market cap
- EV/EBITDA multiple is 22x compared to historical level (75th percentile) of 22.4x
- EV/Sales multiple is 5.1x

At the opening of the session the share price went up +2.4%

------------------------------------------------

2026-09-14

#reports #IESC

[IES](https://eninvs.com/all.php?name=IESC) (Engineering and Construction) reported for 2026 q2
(2026-05-01, Before Market Open):

- Revenue +39.7% YoY (vs +16.8% in previous quarter and historical rate +19.3%)
- EBITDA +61.2% YoY (vs +21.9% in previous quarter and historical rate +57.6%)
- EBITDA margin 15.7% increased compared to 13.6% same period last year
- Net Debt increased by $228 mln over the past reporting period (3.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.8% of market cap
- EV/EBITDA multiple is 12.2x compared to historical level (75th percentile) of 19.5x
- EV/Sales multiple is 1.7x

------------------------------------------------

2026-09-14

#reports #IDXX

[IDEXX Laboratories](https://eninvs.com/all.php?name=IDXX) (Products and services for veterinary medicine producer) reported for 2026 q2
(2026-05-05, Before Market Open):

- Revenue +9.7% YoY (vs +14.3% in previous quarter and historical rate +9.1%)
- EBITDA +19.4% YoY (vs +16.3% in previous quarter and historical rate +11.8%)
- EBITDA margin 38.4% increased compared to 35.3% same period last year
- Net Debt decreased by $7 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$0.9 bln (positive), 2.3% of market cap
- EV/EBITDA multiple is 25.9x compared to historical level (75th percentile) of 38.3x
- EV/Sales multiple is 9x

------------------------------------------------

2026-09-14

#reports #IDXG

[Interpace Biosciences](https://eninvs.com/all.php?name=IDXG) (Diagnostics and Research) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=199412)
(2026-05-12, After Market Close):

- Revenue -10% YoY (vs +290.0% in previous quarter and historical rate +19.6%)
- EBITDA margin 11.1% increased compared to 10.0% same period last year
- Net Debt decreased by $5 mln over the past reporting period (81.5% of market cap)
- FCF (LTM) -$0 bln (negative), 65.2% of market cap
- EV/EBITDA multiple is 0.4x compared to historical level (75th percentile) of 11x
- EV/Sales multiple is 0.1x

------------------------------------------------

2026-09-14

#reports #IDT

[IDT Corporation](https://eninvs.com/all.php?name=IDT) (Telecom Services) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=199411)
(2026-06-03, After Market Close):

- Revenue +4.3% YoY (vs +3.5% in previous quarter and historical rate -0.7%)
- EBITDA +2.9% YoY (vs +13.8% in previous quarter and historical rate +17.5%)
- EBITDA margin 11.1% decreased compared to 11.2% same period last year
- Net Debt decreased by $3 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0.1 bln (positive), 5.6% of market cap
- EV/EBITDA multiple is 11.6x compared to historical level (75th percentile) of 13.1x
- EV/Sales multiple is 1.2x

------------------------------------------------

2026-09-14

#reports #IDCC

[InterDigital](https://eninvs.com/all.php?name=IDCC) (Technology research company) reported for 2026 q2
(2026-04-30, Before Market Open):

- Revenue +23.2% YoY (vs +58.9% in previous quarter and historical rate +33.7%)
- EBITDA +6% YoY (vs +77.2% in previous quarter and historical rate +55.5%)
- EBITDA margin 61.2% decreased compared to 71.1% same period last year
- Net Debt decreased by $7 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.6 bln (positive), 6.3% of market cap
- EV/EBITDA multiple is 15.7x compared to historical level (75th percentile) of 22.1x
- EV/Sales multiple is 9.9x

------------------------------------------------

2026-09-14

#reports #ICUI

[ICU Medical](https://eninvs.com/all.php?name=ICUI) (Peripheral venous catheter producer) reported for 2026 q2
(2026-05-07, After Market Close):

- Revenue +0.5% YoY (vs -12.4% in previous quarter and historical rate -1.7%)
- EBITDA +48.3% YoY (vs +3.2% in previous quarter and historical rate +23.2%)
- EBITDA margin 16.1% increased compared to 10.9% same period last year
- Net Debt decreased by $59 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) +$0.2 bln (positive), 4.0% of market cap
- EV/EBITDA multiple is 17.6x compared to historical level (75th percentile) of 19.6x
- EV/Sales multiple is 2.2x

------------------------------------------------

2026-09-14

#reports #ICLR

[ICON](https://eninvs.com/all.php?name=ICLR) (Clinical trial service provider) reported for 2026 q2
(2026-05-27, After Market Close):

- Revenue +3.1% YoY (vs -0.3% in previous quarter and historical rate +1.5%)
- EBITDA -27.5% YoY (vs -33.0% in previous quarter and historical rate -9.3%)
- EBITDA margin 11.1% decreased compared to 15.8% same period last year
- Net Debt decreased by $181 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0.8 bln (positive), 6.3% of market cap
- EV/EBITDA multiple is 22.8x compared to historical level (75th percentile) of 17.5x
- EV/Sales multiple is 1.9x

------------------------------------------------

2026-09-14

#reports #ICFI

[ICF International](https://eninvs.com/all.php?name=ICFI) (Coach) reported for 2026 q2
(2026-05-07, After Market Close):

- Revenue -0.4% YoY (vs -10.2% in previous quarter and historical rate -1.7%)
- EBITDA -3.6% YoY (vs -9.4% in previous quarter and historical rate +4.6%)
- EBITDA margin 11.2% decreased compared to 11.6% same period last year
- Net Debt decreased by $32 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) +$0.2 bln (positive), 11.7% of market cap
- EV/EBITDA multiple is 10.1x compared to historical level (75th percentile) of 17.7x
- EV/Sales multiple is 1.1x

------------------------------------------------

2026-09-14

#reports #ICE

[Intercontinental Exchange](https://eninvs.com/all.php?name=ICE) (Network of exchanges and clearing houses) reported for 2026 q2
(2026-04-30, Before Market Open):

- Revenue +10.7% YoY (vs +13.5% in previous quarter and historical rate +2.7%)
- Net Income +12.6% YoY (vs +77.3% in previous quarter and historical rate +10.2%)
- Net Income margin 26.5% increased compared to 26.1% same period last year
- P/E multiple is 22.1x compared to historical level (75th percentile) of 19.8x
- P/S multiple is 6.5x
- Price to book: 3x

------------------------------------------------

2026-09-14

#reports #ICCC

[ImmuCell Corporation](https://eninvs.com/all.php?name=ICCC) (Biotechnology) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=197261)
(2026-05-14, After Market Close):

- Revenue +147857.1% YoY (vs +152420.0% in previous quarter and historical rate +57.8%)
- EBITDA margin 19.0% increased compared to 0.0% same period last year
- Net Debt decreased by $3.4 bln since the start of the year (3850.1% of market cap)
- FCF (LTM) +$3.4 bln (positive), 3853.4% of market cap
- EV/Sales multiple is 0.3x

------------------------------------------------

2026-09-14

#reports #IBOC

[International Bancshares](https://eninvs.com/all.php?name=IBOC) (Banking service provider) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=196972)
(2026-05-07, After Market Close):

- Revenue -22.1% YoY (vs +27.0% in previous quarter and historical rate +17.4%)
- Net Income +14.6% YoY (vs +2.3% in previous quarter and historical rate +29.3%)
- Net Income margin 71.1% increased compared to 48.4% same period last year
- P/E multiple is 12.8x compared to historical level (75th percentile) of 12.9x
- P/S multiple is 4.8x
- Price to book: 1.4x

------------------------------------------------

2026-09-14

#reports #HZO

[MarineMax](https://eninvs.com/all.php?name=HZO) (Specialty Retail) reported for [2026 q2](https://eninvs.com/press_release.php?ticker=HZO&q=2026 q2&id=961485)
(2026-07-23, Before Market Open):

- Revenue -7% YoY (vs -16.6% in previous quarter and historical rate -1.4%)
- EBITDA margin 8.2% increased compared to -4.4% same period last year
- Net Debt decreased by $81 mln over the past reporting period (7.1% of market cap)
- FCF (LTM) +$0.2 bln (positive), 15.4% of market cap
- EV/EBITDA multiple is 17.5x compared to historical level (75th percentile) of 19.1x
- EV/Sales multiple is 0.9x

------------------------------------------------

2026-09-14

#reports #HYFM

[Hydrofarm Holdings Group, Inc.](https://eninvs.com/all.php?name=HYFM) (Farm and Heavy Construction Machinery) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=199662)
(2026-03-27):

- Revenue -29.3% YoY (vs -32.4% in previous quarter and historical rate -25.0%)
- EBITDA +40% YoY (vs -1875.0% in previous quarter and historical rate +10.0%)
- EBITDA margin 24.1% increased compared to 12.2% same period last year
- Net Debt increased by $2 mln over the past reporting period (4.4% of market cap)
- FCF (LTM) +$0 bln (positive), 6.6% of market cap
- EV/Sales multiple is 1.6x

------------------------------------------------

2026-09-14

#reports #HY

[Hyster-Yale Materials Handling](https://eninvs.com/all.php?name=HY) (Loaders and spare parts manufacturer) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=198547)
(2026-05-05, After Market Close):

- Revenue -12.6% YoY (vs -13.6% in previous quarter and historical rate +0.2%)
- EBITDA -144.1% YoY (vs -156.5% in previous quarter and historical rate +0.3%)
- EBITDA margin -1.9% decreased compared to 3.7% same period last year
- Net Debt increased by $52 mln over the past reporting period (9.1% of market cap)
- FCF (LTM) +$0 bln (positive), 1.8% of market cap
- EV/Sales multiple is 0.3x

------------------------------------------------

2026-09-14

#reports #HWM

[Howmet Aerospace](https://eninvs.com/all.php?name=HWM) (Engineered metal products provider) reported for 2026 q2
(2026-05-07, Before Market Open):

- Revenue +24.1% YoY (vs +19.1% in previous quarter and historical rate +13.8%)
- EBITDA +34.7% YoY (vs +46.9% in previous quarter and historical rate +28.7%)
- EBITDA margin 31.2% increased compared to 28.7% same period last year
- Net Debt increased by $1.7 bln since the start of the year (1.8% of market cap)
- FCF (LTM) +$0.8 bln (positive), 0.8% of market cap
- EV/EBITDA multiple is 33.8x compared to historical level (75th percentile) of 38.6x
- EV/Sales multiple is 10.6x

------------------------------------------------

2026-09-14

#reports #HWKN

[Hawkins](https://eninvs.com/all.php?name=HWKN) (Specialty Chemicals) reported for 2026 q2
(2026-05-13, After Market Close):

- Revenue +39.8% YoY (vs -1.2% in previous quarter and historical rate +7.4%)
- EBITDA +71% YoY (vs -18.2% in previous quarter and historical rate +23.3%)
- EBITDA margin 16.8% increased compared to 13.7% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.6% of market cap
- EV/EBITDA multiple is 14.9x compared to historical level (75th percentile) of 21.8x
- EV/Sales multiple is 2.5x

------------------------------------------------

2026-09-14

#reports #HWC

[Hancock Whitney](https://eninvs.com/all.php?name=HWC) (Banks — Regional) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=198045)
(2026-04-21, After Market Close):

- Revenue -46.1% YoY (vs -7.5% in previous quarter and historical rate +1.7%)
- Net Income margin 16.5% increased compared to -0.6% same period last year
- P/E multiple is 12.9x compared to historical level (75th percentile) of 16.1x
- P/S multiple is 4.7x
- Price to book: 1.5x

------------------------------------------------

2026-09-14

#reports #HVT

[Haverty Furniture Companies](https://eninvs.com/all.php?name=HVT) (Home Improvement Retail) reported for 2026 q2
(2026-05-05, After Market Close):

- Revenue +7.7% YoY (vs +3.8% in previous quarter and historical rate -7.9%)
- EBITDA +40% YoY (vs +9.1% in previous quarter and historical rate -12.8%)
- EBITDA margin 7.2% increased compared to 5.5% same period last year
- EV/EBITDA multiple is 10.2x compared to historical level (75th percentile) of 10x
- EV/Sales multiple is 0.7x

------------------------------------------------

2026-09-14

#reports #HUN

[Huntsman Corporation](https://eninvs.com/all.php?name=HUN) (Chemical products manufacturer) reported for 2026 q2
(2026-04-30, After Market Close):

- Revenue +14.1% YoY (vs +0.7% in previous quarter and historical rate -2.2%)
- EBITDA margin 6.9% increased compared to -3.3% same period last year
- Net Debt increased by $54 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) -$0 bln (negative), 1.4% of market cap
- EV/EBITDA multiple is 9.2x compared to historical level (75th percentile) of 382.7x
- EV/Sales multiple is 0.6x

------------------------------------------------

2026-09-14

#reports #HUM

[Humana](https://eninvs.com/all.php?name=HUM) (Insurance company) reported for 2026 q2
(2026-02-11, Before Market Open):

- Revenue +27.3% YoY (vs +34.9% in previous quarter and historical rate +16.2%)
- Net Income -30.9% YoY (vs +104.4% in previous quarter and historical rate +9.3%)
- Net Income margin 3.7% decreased compared to 6.8% same period last year
- P/E multiple is 9.8x compared to historical level (75th percentile) of 11.2x
- P/S multiple is 0.4x
- Price to book: 2.8x

------------------------------------------------

2026-09-14

#reports #HUBS

[HubSpot](https://eninvs.com/all.php?name=HUBS) (Platform for marketing and sales) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=196970)
(2026-05-07, After Market Close):

- Revenue +23.4% YoY (vs +20.5% in previous quarter and historical rate +21.6%)
- EBITDA margin 4.9% increased compared to -1.7% same period last year
- Net Debt decreased by $3 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 81.8x compared to historical level (75th percentile) of 14502x
- EV/Sales multiple is 2.8x

------------------------------------------------

2026-09-14

#reports #HTLD

[Heartland Express](https://eninvs.com/all.php?name=HTLD) (Trucking) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=198043)
(2026-04-16, Before Market Open):

- Revenue -12.4% YoY (vs -19.6% in previous quarter and historical rate -16.0%)
- EBITDA +69% YoY (vs +18.5% in previous quarter and historical rate -22.1%)
- EBITDA margin 26.6% increased compared to 13.8% same period last year
- Net Debt decreased by $32 mln over the past reporting period (3.3% of market cap)
- FCF (LTM) -$0 bln (negative), 4.4% of market cap
- EV/EBITDA multiple is 11.4x compared to historical level (75th percentile) of 6.6x
- EV/Sales multiple is 1.4x

------------------------------------------------

2026-09-14

#reports #HSY

[Hershey](https://eninvs.com/all.php?name=HSY) (Confectionery manufacturer) reported for 2026 q2
(2026-07-23, Before Market Open):

- Revenue +6.6% YoY (vs +10.7% in previous quarter and historical rate +4.5%)
- EBITDA +145.7% YoY (vs +58.3% in previous quarter and historical rate +11.6%)
- EBITDA margin 28.0% increased compared to 12.1% same period last year
- Net Debt increased by $338 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) +$1.2 bln (positive), 4.7% of market cap
- EV/EBITDA multiple is 11.8x compared to historical level (75th percentile) of 13.8x
- EV/Sales multiple is 2.5x

------------------------------------------------

2026-09-14

#reports #HSTM

[HealthStream](https://eninvs.com/all.php?name=HSTM) (Health Information Services) reported for 2026 q2
(2026-05-04, After Market Close):

- Revenue +15.1% YoY (vs +11.0% in previous quarter and historical rate +5.7%)
- EBITDA +33.3% YoY (vs +11.8% in previous quarter and historical rate +7.6%)
- EBITDA margin 23.8% increased compared to 20.5% same period last year
- EV/EBITDA multiple is 12.3x compared to historical level (75th percentile) of 14.3x
- EV/Sales multiple is 2.8x

------------------------------------------------

2026-09-14

#reports #HRTX

[Heron Therapeutics](https://eninvs.com/all.php?name=HRTX) (Medical services provider) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=197162)
(2026-02-26, Before Market Open):

- Revenue 0% YoY (vs +20.6% in previous quarter and historical rate +20.5%)
- EBITDA margin -11.4% has not changed compared to -11.4% same period last year
- Net Debt increased by $3 mln over the past reporting period (9.3% of market cap)
- FCF (LTM) +$0 bln (positive), 9.3% of market cap
- EV/Sales multiple is 0.8x

------------------------------------------------

2026-09-14

#reports #HRTG

[Heritage Insurance](https://eninvs.com/all.php?name=HRTG) (Insurance — Property and Casualty) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=199407)
(2026-05-07, After Market Close):

- Revenue +4.4% YoY (vs +232.5% in previous quarter and historical rate +24.7%)
- Net Income +89.5% YoY (vs +935.7% in previous quarter and historical rate +110.8%)
- Net Income margin 16.9% increased compared to 9.3% same period last year
- P/E multiple is 5.1x compared to historical level (75th percentile) of 13x
- P/S multiple is 0.8x
- Price to book: 2.4x

------------------------------------------------

2026-09-14

#reports #HRL

[Hormel Foods](https://eninvs.com/all.php?name=HRL) (Food products provider) reported for 2026 q2
(2026-05-28, Before Market Open):

- Revenue -2.4% YoY (vs +2.6% in previous quarter and historical rate -0.1%)
- EBITDA -41.8% YoY (vs -8.3% in previous quarter and historical rate -13.1%)
- EBITDA margin 6.0% decreased compared to 10.0% same period last year
- Net Debt decreased by $9 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.6 bln (positive), 5.6% of market cap
- EV/EBITDA multiple is 16x compared to historical level (75th percentile) of 14.1x
- EV/Sales multiple is 1.1x

------------------------------------------------

2026-09-14

#reports #HQY

[HealthEquity](https://eninvs.com/all.php?name=HQY) (Financial services provider) reported for 2026 q2
(2026-05-28, After Market Close):

- Revenue +7.7% YoY (vs +7.3% in previous quarter and historical rate +15.1%)
- EBITDA +10.2% YoY (vs +15.6% in previous quarter and historical rate +50.0%)
- EBITDA margin 40.2% increased compared to 39.3% same period last year
- Net Debt decreased by $4 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) +$0.4 bln (positive), 4.5% of market cap
- EV/EBITDA multiple is 15.5x compared to historical level (75th percentile) of 28x
- EV/Sales multiple is 6.6x

------------------------------------------------

2026-09-14

#reports #HQI

[HireQuest](https://eninvs.com/all.php?name=HQI) (Staffing and Employment Services) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=197204)
(2026-05-12, After Market Close):

- Revenue 0% YoY (vs -12.5% in previous quarter and historical rate -5.2%)
- EBITDA 0% YoY (vs -33.3% in previous quarter and historical rate -20.9%)
- EBITDA margin 28.6% has not changed compared to 28.6% same period last year
- Net Debt decreased by $4 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) +$0 bln (positive), 3.1% of market cap
- EV/EBITDA multiple is 24.7x compared to historical level (75th percentile) of 23.5x
- EV/Sales multiple is 7.4x

------------------------------------------------

2026-09-14

#reports #HPQ

[HP](https://eninvs.com/all.php?name=HPQ) (Technologies manufacturer) reported for 2026 q2
(2026-05-27, After Market Close):

- Revenue +12.5% YoY (vs +9.0% in previous quarter and historical rate -2.2%)
- EBITDA +11.2% YoY (vs +2.0% in previous quarter and historical rate -5.8%)
- EBITDA margin 7.2% has not changed compared to 7.3% same period last year
- Net Debt decreased by $972 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) +$4 bln (positive), 10.9% of market cap
- EV/EBITDA multiple is 9.9x compared to historical level (75th percentile) of 6.9x
- EV/Sales multiple is 0.7x

------------------------------------------------

2026-09-14

#reports #HOPE

[Hope](https://eninvs.com/all.php?name=HOPE) (Banks — Regional) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=198040)
(2026-04-28, Before Market Open):

- Revenue -55.6% YoY (vs -13.3% in previous quarter and historical rate +16.7%)
- Net Income margin 24.2% increased compared to 0.4% same period last year
- P/E multiple is 17.6x compared to historical level (75th percentile) of 5.3x
- P/S multiple is 2.2x
- Price to book: 0.7x

------------------------------------------------

2026-09-14

#reports #HOFT

[Hooker Furniture Corporation](https://eninvs.com/all.php?name=HOFT) (Furnishings, Fixtures and Appliances) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=199406)
(2026-04-16, Before Market Open):

- Revenue -18.8% YoY (vs -73.7% in previous quarter and historical rate -14.5%)
- EBITDA margin 4.3% increased compared to -2.4% same period last year
- Net Debt decreased by $3 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) +$0 bln (positive), 11.7% of market cap
- EV/Sales multiple is 0.6x

------------------------------------------------

2026-09-14

#reports #HNVR

[Hanover Bancorp, Inc.](https://eninvs.com/all.php?name=HNVR) (Banks — Regional) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=199693)
(2025-07-23):

- Revenue +23.1% YoY (vs +23.1% in previous quarter and historical rate -3.5%)
- Net Income margin 12.5% increased compared to 7.7% same period last year
- P/E multiple is 19.9x compared to historical level (75th percentile) of 13.5x
- P/S multiple is 3.4x
- Price to book: 1x

------------------------------------------------

2026-09-14

#reports #HNNA

[Hennessy Advisors](https://eninvs.com/all.php?name=HNNA) (Asset Management) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=197160)
(2026-05-13, Before Market Open):

- Revenue +14.3% YoY (vs +33.3% in previous quarter and historical rate +14.1%)
- Net Income 0% YoY (vs 0.0% in previous quarter and historical rate +23.6%)
- Net Income margin 25.0% decreased compared to 28.6% same period last year
- P/E multiple is 5.1x compared to historical level (75th percentile) of 5.9x
- P/S multiple is 1.5x
- Price to book: 0.8x

------------------------------------------------

2026-09-14

#reports #HNI

[HNI Corporation](https://eninvs.com/all.php?name=HNI) (Business Equipment and Supplies) reported for 2026 q2
(2026-07-23, Before Market Open):

- Revenue +120.7% YoY (vs +124.7% in previous quarter and historical rate +29.4%)
- Net Income +6.3% YoY (vs -378.6% in previous quarter and historical rate -0.9%)
- Net Income margin 3.5% decreased compared to 7.2% same period last year
- P/E multiple is 496.6x compared to historical level (75th percentile) of 34.6x
- P/S multiple is 0.5x
- Price to book: 2.4x

------------------------------------------------

2026-09-14

#reports #HLT

[Hilton Worldwide](https://eninvs.com/all.php?name=HLT) (Hotel services provider) reported for 2026 q2
(2026-04-28, Before Market Open):

- Revenue +24% YoY (vs +5.5% in previous quarter and historical rate +10.4%)
- EBITDA +57.2% YoY (vs +37.9% in previous quarter and historical rate +12.6%)
- EBITDA margin 27.1% increased compared to 21.4% same period last year
- EV/EBITDA multiple is 26x compared to historical level (75th percentile) of 31.6x
- EV/Sales multiple is 6.8x

------------------------------------------------

2026-09-14

#reports #HLIT

[Harmonic](https://eninvs.com/all.php?name=HLIT) (Communication Equipment) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=198972)
(2026-05-11, After Market Close):

- Revenue -8.3% YoY (vs -55.9% in previous quarter and historical rate -3.9%)
- EBITDA +76.9% YoY (vs -87.5% in previous quarter and historical rate +15.3%)
- EBITDA margin 18.9% increased compared to 9.8% same period last year
- Net Debt increased by $13 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 25.8x compared to historical level (75th percentile) of 40.9x
- EV/Sales multiple is 2.7x

------------------------------------------------

2026-09-14

#reports #HLIO

[Helios Technologies](https://eninvs.com/all.php?name=HLIO) (Hydraulic and electronic control product manufacturer) reported for 2026 q2
(2026-05-11, After Market Close):

- Revenue +9.4% YoY (vs +16.3% in previous quarter and historical rate +1.5%)
- EBITDA +26.3% YoY (vs +36.4% in previous quarter and historical rate -2.1%)
- EBITDA margin 20.7% increased compared to 17.9% same period last year
- Net Debt decreased by $23 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.9% of market cap
- EV/EBITDA multiple is 15.7x compared to historical level (75th percentile) of 15.5x
- EV/Sales multiple is 2.8x

------------------------------------------------

2026-09-14

#reports #HLI

[Houlihan Lokey](https://eninvs.com/all.php?name=HLI) ( Banking services provider) reported for 2026 q2
(2026-05-06, After Market Close):

- Revenue -78.6% YoY (vs +13.1% in previous quarter and historical rate +21.8%)
- Net Income -87% YoY (vs +23.2% in previous quarter and historical rate +25.2%)
- Net Income margin 15.3% decreased compared to 25.0% same period last year
- P/E multiple is 22.5x compared to historical level (75th percentile) of 31.1x
- P/S multiple is 3.7x
- Price to book: 4x

------------------------------------------------

2026-09-14

#reports #HLF

[Herbalife Nutrition](https://eninvs.com/all.php?name=HLF) (Packaged Foods) reported for 2026 q2
(2026-05-06, After Market Close):

- Revenue +5.4% YoY (vs +7.8% in previous quarter and historical rate +0.6%)
- EBITDA -1.8% YoY (vs +9.1% in previous quarter and historical rate +11.4%)
- EBITDA margin 12.1% decreased compared to 12.9% same period last year
- Net Debt increased by $102 mln over the past reporting period (7.8% of market cap)
- FCF (LTM) +$0.2 bln (positive), 18.7% of market cap
- EV/EBITDA multiple is 5.1x compared to historical level (75th percentile) of 7.6x
- EV/Sales multiple is 0.6x

------------------------------------------------

2026-09-14

#reports #HIVE

[HIVE Blockchain Technologies](https://eninvs.com/all.php?name=HIVE) (Capital Markets) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=199403)
(2026-06-02, Before Market Open):

- Revenue +24.3% YoY (vs +15.0% in previous quarter and historical rate +6.7%)
- Net Income +337.5% YoY (vs +900.0% in previous quarter and historical rate +45.0%)
- Net Income margin 76.1% increased compared to 21.6% same period last year
- P/E multiple is 3.3x compared to historical level (75th percentile) of 11.3x
- P/S multiple is 1.8x
- Price to book: 0.4x

------------------------------------------------

2026-09-14

#reports #HFFG

[HF Foods Group](https://eninvs.com/all.php?name=HFFG) (Food Distribution) reported for [2026 q1](https://eninvs.com/press_release.php?ticker=HFFG&q=2026 q1&id=948620)
(2026-05-13, After Market Close):

- Revenue +2.9% YoY (vs +4.7% in previous quarter and historical rate +32.4%)
- EBITDA +25% YoY (vs +80.0% in previous quarter and historical rate +25.2%)
- EBITDA margin 3.1% increased compared to 2.5% same period last year
- Net Debt increased by $9 mln over the past reporting period (10.1% of market cap)
- FCF (LTM) -$0 bln (negative), 3.4% of market cap
- EV/Sales multiple is 0.2x

------------------------------------------------

2026-09-14

#reports #HEI-A

[HEICO Corporation](https://eninvs.com/all.php?name=HEI-A) (Aerospace products manufacturer) reported for 2026 q2:

- Revenue +28.7% YoY (vs +33.6% in previous quarter and historical rate +36.6%)
- EBITDA +39.4% YoY (vs +49.1% in previous quarter and historical rate +38.6%)
- EBITDA margin 29.3% increased compared to 27.0% same period last year
- EV/EBITDA multiple is 26.7x compared to historical level (75th percentile) of 30.9x
- EV/Sales multiple is 7.6x

------------------------------------------------

2026-09-14

#reports #HEI

[HEICO Corporation](https://eninvs.com/all.php?name=HEI) (Aerospace products manufacturer) reported for 2026 q2
(2026-05-27, After Market Close):

- Revenue +28.7% YoY (vs +33.6% in previous quarter and historical rate +36.6%)
- EBITDA +39.4% YoY (vs +49.1% in previous quarter and historical rate +38.6%)
- EBITDA margin 29.3% increased compared to 27.0% same period last year
- EV/EBITDA multiple is 32.3x compared to historical level (75th percentile) of 30.9x
- EV/Sales multiple is 9.1x

------------------------------------------------

2026-09-14

#reports #HDSN

[Hudson Technologies](https://eninvs.com/all.php?name=HDSN) (Specialty Chemicals) reported for 2026 q2
(2026-05-06, After Market Close):

- Revenue +6.8% YoY (vs +9.1% in previous quarter and historical rate -4.1%)
- EBITDA -38.5% YoY (vs -50.0% in previous quarter and historical rate -38.7%)
- EBITDA margin 10.3% decreased compared to 17.8% same period last year
- EV/EBITDA multiple is 14.3x compared to historical level (75th percentile) of 7.8x
- EV/Sales multiple is 0.8x

------------------------------------------------

2026-09-14

#reports #HCWB

[HCW Biologics Inc.](https://eninvs.com/all.php?name=HCWB) (Biotechnology) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=199661)
(2026-03-31):

- Revenue +218000% YoY (vs +134100.0% in previous quarter and historical rate +150.0%)
- EBITDA margin 51.6% increased compared to -66.7% same period last year
- Net Debt increased by $31.9 bln since the start of the year (33707.1% of market cap)
- FCF (LTM) +$25.6 bln (positive), 27061.6% of market cap
- EV/EBITDA multiple is 7.2x compared to historical level (75th percentile) of 10.3x
- EV/Sales multiple is 0.7x

------------------------------------------------

2026-09-14

#reports #HCTI

[Healthcare Triangle, Inc.](https://eninvs.com/all.php?name=HCTI) (Health Information Services) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=199747)
(2025-11-13):

- Revenue +150% YoY (vs +50.0% in previous quarter and historical rate -7.0%)
- EBITDA margin -30.0% decreased compared to -25.0% same period last year
- Net Debt increased by $21 mln over the past reporting period (1201.7% of market cap)
- FCF (LTM) +$0 bln (positive), 171.7% of market cap
- EV/Sales multiple is 1.1x

------------------------------------------------

2026-09-14

#reports #HCKT

[The Hackett Group](https://eninvs.com/all.php?name=HCKT) (Information Technology Services) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=198531)
(2026-05-05, After Market Close):

- Revenue -11.5% YoY (vs -3.8% in previous quarter and historical rate +1.1%)
- EBITDA +100% YoY (vs +12.5% in previous quarter and historical rate -8.6%)
- EBITDA margin 14.5% increased compared to 6.4% same period last year
- Net Debt increased by $15 mln over the past reporting period (5.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 21.7% of market cap
- EV/EBITDA multiple is 10.3x compared to historical level (75th percentile) of 16.7x
- EV/Sales multiple is 1.2x

------------------------------------------------

2026-09-14

#reports #HCAT

[Health Catalyst](https://eninvs.com/all.php?name=HCAT) (Software provider) reported for 2026 q2
(2026-05-11, After Market Close):

- Revenue -13.6% YoY (vs -10.1% in previous quarter and historical rate +1.2%)
- EBITDA margin -37.1% decreased compared to -29.6% same period last year
- Net Debt increased by $5 mln over the past reporting period (4.1% of market cap)
- FCF (LTM) +$0 bln (positive), 14.1% of market cap
- EV/Sales multiple is 0.6x

------------------------------------------------

2026-09-14

#reports #HBIO

[Harvard Bioscience](https://eninvs.com/all.php?name=HBIO) (Medical Instruments and Supplies) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=199401)
(2026-04-30, Before Market Open):

- Revenue -16% YoY (vs -14.3% in previous quarter and historical rate -9.1%)
- EBITDA margin -4.8% decreased compared to -4.0% same period last year
- Net Debt decreased by $36 mln over the past reporting period (10.9% of market cap)
- FCF (LTM) +$0 bln (positive), 9.7% of market cap
- EV/Sales multiple is 4.1x

------------------------------------------------

2026-09-14

#reports #HBB

[Hamilton Beach Brands Company](https://eninvs.com/all.php?name=HBB) (Furnishings, Fixtures and Appliances) reported for 2026 q2
(2026-05-06, After Market Close):

- Revenue +11.7% YoY (vs -8.3% in previous quarter and historical rate 0.0%)
- EBITDA +557.1% YoY (vs +100.0% in previous quarter and historical rate +61.3%)
- EBITDA margin 32.2% increased compared to 5.5% same period last year
- EV/EBITDA multiple is 5.3x compared to historical level (75th percentile) of 8.7x
- EV/Sales multiple is 0.7x

------------------------------------------------

2026-09-14

#reports #HAYW

[Hayward Holdings, Inc.](https://eninvs.com/all.php?name=HAYW) (Electrical Equipment and Parts) reported for 2026 q2
(2026-02-25, Before Market Open):

- Revenue +6% YoY (vs +11.4% in previous quarter and historical rate +5.3%)
- EBITDA -1.2% YoY (vs +2.1% in previous quarter and historical rate +11.7%)
- EBITDA margin 25.8% decreased compared to 27.7% same period last year
- EV/EBITDA multiple is 11.6x compared to historical level (75th percentile) of 17.5x
- EV/Sales multiple is 2.9x

------------------------------------------------

2026-09-14

#reports #HAS

[Hasbro](https://eninvs.com/all.php?name=HAS) (Entertainment products manufacturer) reported for [2026 q2](https://eninvs.com/press_release.php?ticker=HAS&q=2026 q2&id=960087)
(2026-05-20, Before Market Open):

- Revenue +16.2% YoY (vs +12.7% in previous quarter and historical rate -1.7%)
- EBITDA margin 21.1% increased compared to -80.7% same period last year
- Net Debt decreased by $77 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$1.1 bln (positive), 8.9% of market cap
- EV/EBITDA multiple is 13.2x compared to historical level (75th percentile) of 316.6x
- EV/Sales multiple is 3.1x

------------------------------------------------

2026-09-14

#reports #HALO

[Halozyme Therapeutics](https://eninvs.com/all.php?name=HALO) (Medicines provider) reported for 2026 q2
(2026-05-11, After Market Close):

- Revenue +47.5% YoY (vs +42.3% in previous quarter and historical rate +39.1%)
- EBITDA +39.6% YoY (vs +25.9% in previous quarter and historical rate +38.6%)
- EBITDA margin 60.1% decreased compared to 63.5% same period last year
- Net Debt increased by $149 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$0.6 bln (negative), 4.8% of market cap
- EV/EBITDA multiple is 16.6x compared to historical level (75th percentile) of 31.2x
- EV/Sales multiple is 8.8x

------------------------------------------------

2026-09-14

#reports #HAL

[Halliburton](https://eninvs.com/all.php?name=HAL) (Engineering services provider) reported for [2026 q2](https://eninvs.com/press_release.php?ticker=HAL&q=2026 q2&id=960086)
(2026-07-21, Before Market Open):

- Revenue +3.7% YoY (vs -0.3% in previous quarter and historical rate 0.0%)
- EBITDA +10.5% YoY (vs +37.6% in previous quarter and historical rate -6.2%)
- EBITDA margin 18.8% increased compared to 17.6% same period last year
- EV/EBITDA multiple is 10.5x compared to historical level (75th percentile) of 9.5x
- EV/Sales multiple is 1.7x

------------------------------------------------

2026-09-14

#reports #HAIN

[Hain Celestial](https://eninvs.com/all.php?name=HAIN) (Food products provider) reported for [2026 q1](https://eninvs.com/press_release.php?ticker=HAIN&q=2026 q1&id=948186)
(2026-05-11, Before Market Open):

- Revenue -17.8% YoY (vs -2.8% in previous quarter and historical rate -7.1%)
- EBITDA margin -8.9% increased compared to -19.7% same period last year
- Net Debt decreased by $698 mln over the past reporting period (1260.2% of market cap)
- FCF (LTM) +$0.1 bln (positive), 130.0% of market cap
- EV/Sales multiple is 0.5x

------------------------------------------------

2026-09-14

#reports #HAE

[Haemonetics Corporation](https://eninvs.com/all.php?name=HAE) (Medical equipment developer) reported for 2026 q2
(2026-05-07, Before Market Open):

- Revenue -2.9% YoY (vs -2.0% in previous quarter and historical rate +5.9%)
- EBITDA -3.4% YoY (vs +18.5% in previous quarter and historical rate +18.1%)
- EBITDA margin 25.1% decreased compared to 25.2% same period last year
- Net Debt increased by $90 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) +$0.3 bln (positive), 5.2% of market cap
- EV/EBITDA multiple is 16.4x compared to historical level (75th percentile) of 18.3x
- EV/Sales multiple is 4.3x

------------------------------------------------

2026-09-14

#reports #GWW

[WW Grainger](https://eninvs.com/all.php?name=GWW) (Operating supplies manufacturer) reported for 2026 q2
(2026-05-07, Before Market Open):

- Revenue +10.3% YoY (vs +10.1% in previous quarter and historical rate +5.6%)
- EBITDA +19% YoY (vs +16.6% in previous quarter and historical rate +3.8%)
- EBITDA margin 17.6% increased compared to 16.3% same period last year
- Net Debt increased by $122 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$1.3 bln (positive), 1.9% of market cap
- EV/EBITDA multiple is 22.5x compared to historical level (75th percentile) of 20.3x
- EV/Sales multiple is 3.6x

------------------------------------------------

2026-09-14

#reports #GWRS

[Global Water Resources](https://eninvs.com/all.php?name=GWRS) (Utilities — Regulated Water) reported for 2026 q2
(2026-05-13, After Market Close):

- Revenue +28.6% YoY (vs +8.3% in previous quarter and historical rate +20.6%)
- EBITDA +50% YoY (vs 0.0% in previous quarter and historical rate +18.2%)
- EBITDA margin 50.0% increased compared to 42.9% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0 bln (negative), 4.2% of market cap
- EV/EBITDA multiple is 10.2x compared to historical level (75th percentile) of 18.9x
- EV/Sales multiple is 4.2x

------------------------------------------------

2026-09-14

#reports #GWRE

[Guidewire Software](https://eninvs.com/all.php?name=GWRE) (Software provider) reported for [2026 q1](https://eninvs.com/press_release.php?ticker=GWRE&q=2026 q1&id=957601)
(2026-06-04, After Market Close):

- Revenue +26.9% YoY (vs +24.2% in previous quarter and historical rate +25.4%)
- EBITDA +155.6% YoY (vs +116.0% in previous quarter and historical rate +111.7%)
- EBITDA margin 12.3% increased compared to 6.1% same period last year
- Net Debt increased by $214 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) +$0.3 bln (positive), 2.7% of market cap
- EV/EBITDA multiple is 67.1x compared to historical level (75th percentile) of 486x
- EV/Sales multiple is 8.3x

------------------------------------------------

2026-09-14

#reports #GTN

[Gray Television](https://eninvs.com/all.php?name=GTN) (Telecommunications company) reported for 2026 q2
(2026-05-07, Before Market Open):

- Revenue +7.3% YoY (vs -19.2% in previous quarter and historical rate -4.6%)
- EBITDA +23.2% YoY (vs -56.0% in previous quarter and historical rate -11.6%)
- EBITDA margin 22.8% increased compared to 19.8% same period last year
- Net Debt increased by $157 mln over the past reporting period (35.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 18.6% of market cap
- EV/EBITDA multiple is 9.7x compared to historical level (75th percentile) of 7x
- EV/Sales multiple is 2x

------------------------------------------------

2026-09-14

#reports #GTLS

[Chart Industries](https://eninvs.com/all.php?name=GTLS) (Industrial equipment manufacturer) reported for 2026 q1
(2026-02-27, Before Market Open):

- Revenue -11.7% YoY (vs -2.4% in previous quarter and historical rate +47.7%)
- EBITDA -43.4% YoY (vs -23.3% in previous quarter and historical rate +55.8%)
- EBITDA margin 14.0% decreased compared to 21.9% same period last year
- Net Debt increased by $186 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.7% of market cap
- EV/EBITDA multiple is 20.7x compared to historical level (75th percentile) of 15.8x
- EV/Sales multiple is 2.7x

------------------------------------------------

2026-09-14

#reports #GTIM

[Good Times Restaurants](https://eninvs.com/all.php?name=GTIM) (Restaurants) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=196966)
(2026-05-07, After Market Close):

- Revenue -2.9% YoY (vs -8.3% in previous quarter and historical rate -4.3%)
- EBITDA 0% YoY (vs 0.0% in previous quarter and historical rate -2.8%)
- EBITDA margin 6.1% increased compared to 5.9% same period last year
- Net Debt decreased by $1 mln over the past reporting period (6.2% of market cap)
- FCF (LTM) +$0 bln (positive), 37.4% of market cap
- EV/EBITDA multiple is 10.4x compared to historical level (75th percentile) of 13.5x
- EV/Sales multiple is 0.4x

------------------------------------------------

2026-09-14

#reports #GTES

[Gates Industrial Corporation plc](https://eninvs.com/all.php?name=GTES) (Specialty Industrial Machinery) reported for 2026 q2
(2026-05-01, Before Market Open):

- Revenue +6.6% YoY (vs +0.4% in previous quarter and historical rate +16.1%)
- EBITDA +11.8% YoY (vs -6.7% in previous quarter and historical rate +27.4%)
- EBITDA margin 20.1% increased compared to 19.1% same period last year
- Net Debt decreased by $33 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0.2 bln (positive), 2.1% of market cap
- EV/EBITDA multiple is 7.4x compared to historical level (75th percentile) of 10.1x
- EV/Sales multiple is 1.5x

------------------------------------------------

2026-09-14

#reports #GSIT

[GSI Technology](https://eninvs.com/all.php?name=GSIT) (Semiconductors) reported for 2026 q2
(2026-07-23, After Market Close):

- Revenue 0% YoY (vs +20.0% in previous quarter and historical rate -3.1%)
- EBITDA margin -83.3% decreased compared to -33.3% same period last year
- Net Debt increased by $80 mln over the past reporting period (45.4% of market cap)
- FCF (LTM) -$0 bln (negative), 8.5% of market cap
- EV/Sales multiple is 4x

------------------------------------------------

2026-09-14

#reports #GSHD

[Goosehead Insurance](https://eninvs.com/all.php?name=GSHD) (Insurance services provider) reported for [2026 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=198521)
(2026-02-17, After Market Close):

- Revenue +19.2% YoY (vs +64.1% in previous quarter and historical rate +29.2%)
- Net Income -27.3% YoY (vs +950.0% in previous quarter)
- Net Income margin 8.6% decreased compared to 14.1% same period last year
- P/E multiple is 21.7x compared to historical level (75th percentile) of 80.7x
- P/S multiple is 3.8x
- Price to book: -13.2x

Switch to company model in classical logic    *